Skip to content
lifestyle.pspl.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Evaxion
Evaxion to announce strategy and business update and third quarter 2026 financial results on November 19, 2026
November 18, 2026
Evaxion announce 2027 financial calendar
November 12, 2026
Evaxion files amendment to registration statement related to 2025 EIB debt settlement agreement
November 9, 2026
New phase 2 data highlight the strength of the immune response induced by personalized cancer vaccine EVX-01
November 6, 2026
Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting
November 4, 2026
Evaxion to present broad biomarker data from phase 2 trial with personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting
November 3, 2026
Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution
October 30, 2026
Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01
October 23, 2026
Evaxion reports sustained clinical responses for all patients at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01
October 19, 2026
Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting
October 2, 2026
1
2
Next Page
→